iShares Russell 2000 Growth ETF (IWO)

199.39 -0.42  -0.21% NYSE Arca May 29, 20:00 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 199.67
Discount or Premium to NAV -0.14%
Turnover Ratio 35.00%
1 Year Fund Level Flows -491.27M
View All IWO News

News

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 5.27% 5.52% 10.99% 62
3M 1.41% 1.74% 2.75% 56
6M -4.62% -4.51% -3.28% 58
YTD -6.73% -6.65% -4.48% 59
1Y 5.76% 5.81% 4.84% 51
3Y 7.43% 7.47% 9.14% 59
5Y 6.39% 6.40% 7.51% 64
10Y 11.77% 11.80% 11.71% 56
15Y 8.81% 8.84% 8.78% 56
20Y -- -- 7.63% --
As of May 29, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.12% 0.12% 0.00%
Stock 99.88% 99.88% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of May 28, 2020

Region Exposure

Americas 99.75%
North America 99.58%
Latin America 0.18%
Greater Europe 0.15%
United Kingdom 0.06%
Europe Developed 0.06%
Europe Emerging 0.04%
Africa/Middle East 0.00%
Greater Asia 0.09%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.09%
Asia Emerging 0.00%
Market Classification
% Developed Markets 99.96%
% Emerging Markets 0.04%
As of May 28, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 3.00%
Communication Services 2.67%
Consumer Cyclical 8.61%
Consumer Defensive 4.61%
Energy 0.34%
Financial Services 5.48%
Healthcare 33.89%
Industrials 17.79%
Real Estate 3.92%
Technology 18.18%
Utilities 1.51%
As of May 28, 2020

Stock Market Capitalization

Giant 0.00%
Large 0.00%
Medium 24.19%
Small 66.84%
Micro 8.97%
As of May 28, 2020

Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 0.00%
Large Cap Growth 0.00%
Mid Cap Value 0.67%
Mid Cap Blend 5.24%
Mid Cap Growth 19.20%
Small Cap Value 7.35%
Small Cap Blend 22.53%
Small Cap Growth 45.02%
As of May 28, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
TDOC Teladoc Health Inc 1.21% 174.06 +4.29%
GNRC Generac Holdings Inc 0.72% 111.27 -5.70%
CHGG Chegg Inc 0.72% 61.08 +1.01%
TREX Trex Co Inc 0.70% 120.12 +0.30%
RGEN Repligen Corp 0.68% 130.97 +1.36%
IMMU Immunomedics Inc 0.62% 33.59 +0.87%
FIVN Five9 Inc 0.60% 104.20 +3.27%
AMED Amedisys Inc 0.60% 192.05 +0.59%
QDEL Quidel Corp 0.60% 175.00 +4.65%
NVCR NovoCure Ltd 0.58% 67.43 +0.52%
As of May 28, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks to track the investment results of the Russell 2000 Growth Index, which measures the performance of the small-capitalization growth sector of the U.S. equity market. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which the advisor believes will help the fund track the underlying index.
General
Security Type Exchange-Traded Fund
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Small Growth
Prospectus Objective Growth
Fund Owner Firm Name iShares
Benchmark Index
Russell 2000 Growth TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Alan Mason 4.04 yrs
Amy Whitelaw 1.75 yrs
Greg Savage 12.34 yrs
Jennifer Hsui 7.75 yrs
Rachel Aguirre 1.75 yrs

Net Fund Flows

1M -102.56M
3M -376.00M
6M -176.37M
YTD -433.81M
1Y -491.27M
3Y -631.42M
5Y -537.01M
10Y -139.48M
As of April 30, 2020

Risk Info

Beta (5Y) 1.257
Max Drawdown (All) 60.10%
Historical Sharpe Ratio (10Y) 0.5658
Historical Sortino (All) 0.3302
30-Day Rolling Volatility 37.83%
Daily Value at Risk (VaR) 1% (All) 4.09%
Monthly Value at Risk (VaR) 1% (All) 20.76%

Fundamentals

Dividend Yield TTM (5-29-20) 0.77%
30-Day SEC Yield (3-31-20) 0.94%
7-Day SEC Yield --
Weighted Average PE Ratio 20.51
Weighted Average Price to Sales Ratio 1.424
Weighted Average Price to Book Ratio 3.420
Weighted Median ROE 2.25%
Weighted Median ROA -3.12%
Forecasted Dividend Yield 0.92%
Forecasted PE Ratio 22.43
Forecasted Price to Sales Ratio 1.315
Forecasted Price to Book Ratio 2.815
Number of Holdings 1166
As of May 28, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 12.63%
Forecasted Book Value Growth 8.24%
Forecasted Cash Flow Growth 12.96%
Forecasted Earnings Growth 8.06%
Forecasted Revenue Growth 7.18%
As of May 28, 2020

Comparables

Edit

Attributes

Key Dates
Inception Date 7/24/2000
Termination Date
Last Annual Report Date 3/31/2019
Last Prospectus Date 8/1/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.